Cannabinoids

Applications 4-Nitro-benzeneethanol is a useful synthetic intermediate. It can be used to synthesize N-phenylethylindole carboxamides as SAR study of allosteric modulators of CB1 receptor. It can also be used to prepare 2-aza-2'-deoxyinosine-containing oligodeoxyribonucleotide duplexes.
References Piscitelli, F., et al.: J. Med. Chem., 55, 5627 (2012); Acedo, M., et al.: J. Org. Chem., 60, 6262 (1995)

Applications 1-Alkyl-2-aryl-4-(1-naphthoyl)pyrroles as high affinity ligands for the cannabinoid CB1 and CB2 receptors.
References Reggio, P., et al.: J. Med. Chem., 41, 5177 (1998), Huffman, J., et al.: Bioorg. Med. Chem., 11, 539 (2003),

Applications Used in the preparation of CB1 cannabinoid receptor agonists and brain imaging agents.
References Deng, H. et al; J. Med. Chem. 48, 6386 (2005)

Applications A cannabimimetic indole derivative that acts as a CB2 receptor agonist with weak CB2 activity. It has been shown to possess immunomodulatory effects and may be useful in the treatment of pain and inflammation. Synthetic cannabinoids
References Aung, M.M. et al.: Drug Alc. Depend., 60, 133 (2000); Ghosh, S. et al.: Mol. Immunol., 43, 2169 (2006); Ehrhart, J. et al.: J. Neuroinflam., 2, 29 (2005); Romero-Sandoval, A. et al.: Anethesiol., 106, 787 (2007);

Applications An intermediate of synergistic pesticide Boscalid. Also, used in the preparation of thieno[2.3-b]pyrrole derivatives as cannabinoid receptor agonists useful in mono- and combination therapy of diseases.
References Granger, D., et al.: Arthritis Rheum., 37, 1053 (1994), Robinson, R., et al.: J. Med. Chem., 39, 10 (1996),

Stability Light Sensitive
Applications (Z)-1-(3,5-Bis(benzyloxy)phenyl)pent-1-en-3-one is a reagent in the synthesis of 3''-Hydroxycannabidiol (H824825) which is a major constituents in marijuana. 3''-Hydroxycannabidiol be used to investigate canabidiol metabolism and human liver microsomes that metabolize Canabidiol into 6α-Hydroxycannabidiol.
References Jiang, R., et al.: Life Sci. 89, 165 (2011); Lander, N., et al.: Science 169, 611 (1970)

Applications Labelled analogue of a cannabimimetic indole derivative that acts as both a cannabinoid receptor CB1 and CB2 agonist.
References Huffman J.W. et al.: Bioorg. Med. Chem. Lett., 15, 4110 (2005); De Freitas, G.B.L. et al.: Eur. J. Med. Chem., 44, 2482 (2009); Tuccinardi, T. et al.: J. Med. Chem., 49, 984 (2006);

Applications A potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor. (AM2233) had a very high affinity for the rat CB1 receptor, with most of the affinity residing with the (R)-enantiomer.Synthetic Cannabinoids
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Neumeyer, J., et al.: J. Med. Chem., 33, 521 (1990), D'Ambra, T., et al.: Bioorg. Med. Chem. Lett., 6, 17 (1996), Schatz, A., et al.: Toxicol. Appl. Pharmacol., 142, 278 (1997),

Applications Reactant in the preparation of CB1 cannabinoid receptor agonists and brain imaging agents.
References Deng, H. et al; J. Med. Chem. 48, 6386 (2005)

Applications (4R,7S)Tedalinab is a stereoisomer of Tedalinab(T013730) is a cannabinoid receptor modulator that is useful for treating non-immediate type allergic diseases.
References Muthuppalaniappan, M., et al.: PCT Int. Appl. WO 2006129178 A1 20061207. Dec 7, 2006; Narayanan, S., et al.: U.S. Pat. Appl. Publ. US 20090312385 A1 20091217. Dec 17, 2009

Applications Tedalinab is a cannabinoid receptor modulator that is useful for treating non-immediate type allergic diseases.
References Muthuppalaniappan, M., et al.: PCT Int. Appl. WO 2006129178 A1 20061207. Dec 7, 2006; Narayanan, S., et al.: U.S. Pat. Appl. Publ. US 20090312385 A1 20091217. Dec 17, 2009

Applications 4-Methyl-5-pentylbenzene-1,3-diol is a secondary metabolite of SteelyA polyketide synthase, which controls cell aggregation and spore maturation of Dictyostelium discoideum;Also, it is an intermediate used in the synthesis of 4-Methyl Cannabigerol (M295365), which is analog of Cannabigerol (C175370), which is a partial agonist of CB2 and CB1 receptors. Cannabigerol (C175370), a non-psychoactive cannabinoid, also exhibits α2-adrenoceptor agonist activity (EC50 = 0.2 nM in mouse brain membranes).
References Murata, C., et al.: Bioorg. Med. Chem. Lett., 26, 1428-1433 (2016); Sato, Y. G., et al.: Biosci. Biotechnol. Biochem., 77, 2008-2012 (2013); Watanabe, K., et al.: Biol. Pharm. Bull., 18, 1138 (1995), Iverson, L., et al.: Brain, 126, 1252 (2003), Hayakawa, K., et al.: Brain Res., 1188, 157 (2008), Wright, K., et al.: Br. J. Pharmacol., 153, 263 (2008)